WASHINGTON, August 2, 2017 - The Food and Drug Administration has approved a qualified health claim linking consumption of soybean oil to reduced risk of coronary heart disease. The petition, filed by Bunge North America, pointed to the potential heart health benefits of soybean oil.

The FDA action means manufacturers may now tout a claim that soybean oil may reduce coronary heart disease risk and lower LDL-cholesterol when replacing saturated fat and not increasing calories. The claim is similar to those associated with canola, corn and olive oil and states that eating 1.5 tablespoons of soybean oil daily may reduce the risk of coronary heart disease when replacing saturated fat and not increasing calories. “The food industry is by far our largest customer for soybean oil and by submitting this claim Bunge is really looking out for soybean farmers and our long-term profitability,” says John Motter, United Soybean Board chairman and soybean farmer from Jenera, Ohio. “This claim really helps U.S. soybean farmers maintain their competitiveness in this critical market and helps us compete with other oils that have become synonymous with heart health.” T

he American Heart Association recently went on record regarding the cardiovascular benefits of the fats found in soybean oil.